INTERNATIONAL PATENT: LYELL IMMUNOPHARMA, INC. FILES APPLICATION FOR "T CELLS COMPRISING A CHIMERIC ANTIGEN RECEPTOR TARGETING TRANSFORMING GROWTH FACTOR BETA AND A T CELL RECEPTOR TARGETING A TUMOR ANTIGEN AND USE THEREOF"

GENEVA, May 14 -- LYELL IMMUNOPHARMA, INC. (201 Haskins Way, Suite 101South San Francisco, California 94080) filed a patent application (PCT/US2024/053379) for "T CELLS COMPRISING A CHIMERIC ANTIGEN RECEPTOR TARGETING TRANSFORMING GROWTH FACTOR BETA AND A T CELL RECEPTOR TARGETING A TUMOR ANTIGEN, AND USE THEREOF" on Oct 29, 2024. With publication no. WO/2025/096419, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEIST, Michael R. (c/o ImmPACT Bio USA, Inc.8501 Fallbrook Avenue, Suite 200West Hills, California 91304), JO...